---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258806514.md"
description: "Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines"
datetime: "2025-09-25T05:43:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258806514.md)
  - [en](https://longbridge.com/en/news/258806514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258806514.md)
generator: "portal-rs"
---

# 

Innovative drug concept stocks surged and then fell back, with Amgen Pharmaceuticals dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with significant declines

### Related Stocks

- [688166.CN](https://longbridge.com/en/quote/688166.CN.md)
- [301096.CN](https://longbridge.com/en/quote/301096.CN.md)
- [688658.CN](https://longbridge.com/en/quote/688658.CN.md)
- [603590.CN](https://longbridge.com/en/quote/603590.CN.md)
- [688513.CN](https://longbridge.com/en/quote/688513.CN.md)
- [300497.CN](https://longbridge.com/en/quote/300497.CN.md)

## Related News & Research

- [Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares](https://longbridge.com/en/news/296370263.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [CANSINOBIO  Tetanus Vaccine New Drug Application Approved](https://longbridge.com/en/news/296498620.md)
- [OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian](https://longbridge.com/en/news/296607308.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**